Detection of cerebral perfusion abnormalities in acute stroke using phase inversion harmonic imaging (PIHI): preliminary results.
J Eyding, C Krogias, W Wilkening...
https://pubmed.ncbi.nlm.nih.gov/15146019Actively Recruiting
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-19
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating brain tissue perfusion in patients with acute brain injuries using contrast-enhanced ultrasound perfusion imaging (PerCEUS). This study aims to assess the unevenness of brain blood flow to diagnose areas of poor perfusion and to compare these findings with standard multimodal monitoring techniques. The study focuses on patients admitted to neurointensive care with confirmed acute brain injuries. The PerCEUS procedure involves using a specialized ultrasound machine to perform imaging at the patient's bedside, targeting specific brain regions identified by MRI or CT scans. The imaging captures detailed perfusion data within about 5 minutes, focusing on the lesion core, surrounding tissue, and the corresponding area in the opposite hemisphere. This imaging is done alongside routine monitoring methods such as intracranial pressure, cerebral perfusion pressure, arterial pressure, cerebral oxygen saturation, and jugular venous oxygen levels. Participants undergo the PerCEUS imaging shortly after hospital admission when contrast ultrasound is needed, without delaying emergency care. The study session lasts approximately 30 minutes, including 25 minutes of observation after the imaging. Researchers analyze the data offline, measuring perfusion heterogeneity through time-to-peak and peak intensity, and correlate these with standard monitoring results. The study concludes with safety oversight, aiming to improve understanding of brain blood flow in acute injury situations.
CONDITIONS
Brain PERfusion Evaluation by Contrast-Enhanced UltraSound
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 30 minutes
Participants undergo contrast-enhanced ultrasound perfusion imaging (PerCEUS) at the bedside to evaluate brain perfusion heterogeneity and correlate with multimodal monitoring parameters.
1 visit (in-person)
Total: 1 location
1
Lariboisière Hospital
Paris, France, 75010
Actively Recruiting
R
Romain BARTHELEMY, MD
B
Benjamin Glenn CHOUSTERMAN, MD PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J Eyding, C Krogias, W Wilkening...
https://pubmed.ncbi.nlm.nih.gov/15146019Jens Eyding, Christian Fung, Wolf-Dirk Niesen...
https://pubmed.ncbi.nlm.nih.gov/32192077Elisabeth J Vinke, Anna J Kortenbout, Jens Eyding...
https://pubmed.ncbi.nlm.nih.gov/28964614Christian Fung, Dieter Henrik Heiland, Raluca Reitmeir...
https://pubmed.ncbi.nlm.nih.gov/35211837Federico Bilotta, Chiara Robba, Antonio Santoro...
https://pubmed.ncbi.nlm.nih.gov/27475927